Skip to content

Author

Zhou-Yu Song

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Daraxonrasib Treatment in RAS-Mutated Pancreatic Cancer: Mechanisms, Clinical Evidence and Future Perspectives

A review explores the pathogenic role of KRAS mutations in pancreatic cancer, traces the development and mechanism of daraxonrasib, evaluates supporting clinical data, and discusses its strengths, limitations, and future positioning in managing RAS-mutated PDAC.

Zhou-Yu Song · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.